Holen Sie sich die Stockscreener-App
72.14
1.28%
0.7927
Schlusskurs vom Vortag:
$71.35
Offen:
$70.32
24-Stunden-Volumen:
7.37M
Relative Volume:
0.53
Marktkapitalisierung:
$106.78B
Einnahmen:
$20.08B
Nettoeinkommen (Verlust:
$2.89B
KGV:
37.20
EPS:
1.9391
Netto-Cashflow:
$3.66B
1W Leistung:
-5.20%
1M Leistung:
-2.51%
6M Leistung:
-33.15%
1J Leistung:
-27.11%
1-Tages-Spanne:
$69.52
$72.37
1-Wochen-Bereich:
$69.52
$76.37
52-Wochen-Spanne:
$69.52
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
71.96 | 105.88B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
ABT
Abbott Laboratories
|
112.37 | 190.38B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
366.60 | 139.51B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
91.19 | 116.71B | 35.48B | 4.64B | 5.41B | 3.582 |
|
EW
Edwards Lifesciences Corp
|
83.91 | 47.42B | 6.07B | 1.06B | 1.34B | 1.8063 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-03 | Herabstufung | Erste Group | Buy → Hold |
| 2025-09-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-16 | Hochstufung | Needham | Hold → Buy |
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - TMX Newsfile
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Boston Scientific Investor Sues Over Growth Projections - Law360
Boston Scientific Overpromised Segment’s Performance, Suit Says - Bloomberg Law News
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit - Barchart.com
BSX Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Boston Scientific Corporation – Company AnnouncementFT.com - Financial Times
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX) - marketscreener.com
Rosen Law Firm Urges Boston Scientific Corporation (NYSE: BSX) Stockholders to Contact the Firm for Information About Their Rights - ChartMill
Boston Scientific’s ENTRUST Registry Targets Real-World Edge in Carotid Stroke Prevention - TipRanks
Why Is Boston Scientific (BSX) Down 6% Since Last Earnings Report? - Yahoo Finance
Boston Scientific to explain new ACC heart data to investors - Stock Titan
Boston Scientific to host investor event at the 75th Annual Scientific Session of the American College of Cardiology - Financial Times
Investor Notice: Robbins LLP Informs Investors of the Boston Scientific Corporation Class Action Lawsuit - The AI Journal
Boston Scientific (BSX) Advances While Market Declines: Some Information for Investors - Yahoo Finance
3 Reasons Boston Scientific Stock Could Quietly 5X as the World Ages - Nasdaq
April 24th Options Now Available For Boston Scientific (BSX) - Nasdaq
Boston Scientific (BSX) Raises Share Buyback Authorization To $5B - Finviz
Is It Time To Reconsider Boston Scientific (BSX) After The Recent Share Price Pullback - Yahoo Finance
Boston Scientific Target of Unusually Large Options Trading (NYSE:BSX) - MarketBeat
Boston Scientific : 3 ways we're reducing the environmental impact of our devices - marketscreener.com
Boston Scientific stock hits 52-week low at 72.63 USD - Investing.com South Africa
TD Cowen reiterates Boston Scientific stock rating on guidance confidence - Investing.com
Boston Scientific Corporation $BSX Shares Sold by Teachers Retirement System of The State of Kentucky - MarketBeat
BSX Earnings History & Surprises | EPS & Revenue Results | BOSTON SCIENTIFIC CORP (NYSE:BSX) - ChartMill
Boston Scientific: Near-Term EP Reset but 2027 Growth Drivers Support Buy Rating - TipRanks
1 Healthcare Stock to Target This Week and 2 Facing Challenges - Finviz
Penumbra Sale To Boston Scientific Puts Focus On Deal Terms And Future - simplywall.st
Boston Scientific (BSX) SVP converts RSUs, withholds 372 shares for taxes - Stock Titan
Boston Scientific (NYSE: BSX) Explains Rationale for Penumbra Deal - Stock Titan
Boston Scientific Corp Stock Moved Down by 3.32% on Mar 3: Facts Behind the Movement - TradingKey
Boston Scientific Corp. Experiences Evaluation Revision Amid Mixed Market Signals - Markets Mojo
Boston Scientific Corp.: Why This Quiet Medtech Giant Matters to You - AD HOC NEWS
Segall Bryant & Hamill LLC Has $23.51 Million Position in Boston Scientific Corporation $BSX - MarketBeat
The Zacks Analyst Blog Highlights Apple, TotalEnergies, Boston Scientific and Good Times Restaurants - Bitget
Boston Scientific gets Farapulse label expansion in Europe - Yahoo Finance
Boston Scientific Corp.: Why This Quiet Medtech Giant Is Suddenly On Watch - AD HOC NEWS
FDA recalls Boston Scientific stents, following three deaths, 160+ serious injuries - Worcester Business Journal
Boston Scientific wins expanded CE mark for Farapulse in persistent AFib - MassDevice
Boston Scientific Corporation (BSX) Stock Analysis: With a 36.3% Potential Upside, Is It Time to Invest? - DirectorsTalk Interviews
Andra AP fonden Buys 18,900 Shares of Boston Scientific Corporation $BSX - MarketBeat
111 Capital Makes New Investment in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX): Buy, Sell, or Hold Post Q4 Earnings? - Finviz
Levi & Korsinsky Investigates Possible Securities Fraud by Boston Scientific Corporation (BSX) - marketscreener.com
Austin InnoA huge medtech acquisition | Mental health startup launches subscription - The Business Journals
Vaginal Mesh Lawsuit Settlements | March 2026 Update - Lawsuit Information Center
TIAA Trust National Association Has $19.28 Million Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Stock Holdings Raised by Egerton Capital UK LLP - MarketBeat
American Century Companies Inc. Has $390.43 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
Boston Scientific (NYSE: BSX) EVP logs 6,851-share 401(k) rebalancing move - Stock Titan
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.07%
0.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):